Ranolazine in Cardiac Arrhythmia
Copyright policy )Ranolazine in Cardiac Arrhythmia
ABSTRACTRanolazine utilization in the management of refractory angina has been established by multiple randomized clinical studies. However, there is growing evidence showing an evolving role in the field of cardiac arrhythmias. Multiple experimental and clinical studies have evaluated the role of ranolazine in prevention and management of atrial fibrillation, with ongoing studies on its role in ventricular arrhythmias. In this review, we will discuss the pharmacological, experimental, and clinical evidence behind ranolazine use in the management of various cardiac arrhythmias.
- Trinitas Regional Medical Center United States
- Seton Hill University United States
- University of Florida United States
Action Potentials, Arrhythmias, Cardiac, Sodium Channels, Kinetics, Treatment Outcome, Heart Conduction System, Heart Rate, Ranolazine, Animals, Humans, Anti-Arrhythmia Agents, Sodium Channel Blockers
Action Potentials, Arrhythmias, Cardiac, Sodium Channels, Kinetics, Treatment Outcome, Heart Conduction System, Heart Rate, Ranolazine, Animals, Humans, Anti-Arrhythmia Agents, Sodium Channel Blockers
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).24 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!